Sustained alzheimer's amyloid pathology in myeloid differentiation protein-88-deficient APPswe/PS1 Mice

Neurodegenerative Diseases

Volumn 13, Issue 2-3, 2014, Pages 58-60

  Goll, Y ^a   Bekenstein, U ^a   Barbash, S ^a   Greenberg, D S ^a   Zangen, R ^a   Shoham, S ^a   Soreq, H ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Alzheimer's disease; Amyloid , APPsw PS1 E9 mice; Myeloid differentiation protein 88; Toll like receptor

Indexed keywords

AMYLOID BETA PROTEIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; FEMALE; GENOTYPE; HETEROZYGOTE; INNATE IMMUNITY; LIFE EXPECTANCY; MALE; MICROGLIA; MORTALITY; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; ANTIBODY RESPONSE; BRAIN REGION; CONFERENCE PAPER; HIPPOCAMPUS; IMMUNE RESPONSE; NEUROIMMUNOLOGY; PROGENY; STAINING; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; MICE; MICE, TRANSGENIC; MYELOID DIFFERENTIATION FACTOR 88; PLAQUE, AMYLOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84896696240     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000353689     Document Type: Article

References (22)

1. Querfurth HW, LaFerla FM: Alzheimer's disease. N Engl J Med 2010; 362: 329-344.
2. Tan J, Town T, Paris D, et al: Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 1999; 286: 2352-2355.
3. Scholtzova H, Kascsak RJ, Bates KA, et al: Induction of Toll-like receptor 9 signaling as a method for ameliorating Alzheimer's diseaserelated pathology. J Neurosci 2009; 29: 1846-1854.
4. Qiu WQ, Ye Z, Kholodenko D, Seubert P, Selkoe DJ: Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells. J Biol Chem 1997; 272: 6641-6646.
5. El Khoury J, Toft M, Hickman SE, et al: Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 2007; 13: 432-438.
6. El Khoury JB, Moore KJ, Means TK, et al: CD36 mediates the innate host response to beta-amyloid. J Exp Med 2003; 197: 1657-1666.
7. Heneka MT, O'Banion MK, Terwel D, Kummer MP: Neuroinflammatory processes in Alzheimer's disease. J Neural Transm 2010; 117: 919-947.
8. Barbash S, Soreq H: Threshold-independent meta-analysis of Alzheimer's disease transcriptomes shows progressive changes in hippocampal functions, epigenetics and micro-RNA regulation. Curr Alzheimer Res 2012; 9: 425-435.
9. Adachi O, Kawai T, Takeda K, et al: Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function. Immunity 1998; 9: 143-150.
10. Berson A, Barbash S, Shaltiel G, et al: Cholinergic-associated loss of hnRNP-A/B in Alz-heimer's disease impairs cortical splicing and cognitive function in mice. EMBO Mol Med 2012; 4: 730-742.
11. Rees T, Hammond PI, Soreq H, Younkin S, Brimijoin S: Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol Aging 2003; 24: 777-787.
12. Grathwohl SA, Kalin RE, Bolmont T, et al: Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat Neurosci 2009; 12: 1361-1363.
13. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA: Dementia and adultonset unprovoked seizures. Neurology 1996; 46: 727-730.
14. Minkeviciene R, Rheims S, Dobszay MB, et al: Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci 2009; 29: 3453-3462.
15. Benilova I, Karran E, De Strooper B: The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci 2012; 15: 349-357.
16. Leissring MA, Farris W, Chang AY, et al: Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 2003; 40: 1087-1093.
17. Kilger E, Buehler A, Woelfing H, et al: BRI2 protein regulates beta-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE). J Biol Chem 2011; 286: 37446-37457.
18. Michaud JP, Richard KL, Rivest S: Hematopoietic MyD88-adaptor protein acts as a natural defense mechanism for cognitive deficits in Alzheimer's disease. Stem Cell Rev 2012; 8: 898-904.
19. Lim JE, Kou J, Song M, et al: MyD88 deficiency ameliorates beta-amyloidosis in an animal model of Alzheimer's disease. Am J Pathol 2011; 179: 1095-1103.
20. Michaud JP, Richard KL, Rivest S: MyD88-adaptor protein acts as a preventive mechanism for memory deficits in a mouse model of Alzheimer's disease. Mol Neurodegener 2011; 6: 5.
21. Hsiao KK, Borchelt DR, Olson K, et al: Agerelated CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 1995; 15: 1203-1218.
22. Ittner LM, Ke YD, Delerue F, et al: Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 2010; 142: 387-397.